Latest European patent oppositions filed by Elkington And Fife Llp
Patent Number | Title | Applicant | Opposition Date |
---|---|---|---|
EP3263106 | Method For Suppressing Bitterness Of Quinoline Derivative | EISAI R&D MANAGEMENT CO., LTD. | 2024-07-25 |
EP3626270 | New Use | NOVARTIS AG | 2024-07-11 |
EP3500241 | Combination Therapy For Copd | CHIESI FARMACEUTICI S.P.A. | 2024-07-04 |
EP3175853 | Antineoplastic Combinations Of Neratinib And Capecitabine | WYETH LLC | 2024-07-02 |
EP3263106 | Method For Suppressing Bitterness Of Quinoline Derivative | EISAI R&D MANAGEMENT CO., LTD. | 2024-06-20 |
EP3650019 | Fluticasone Furoate In The Treatment Of Copd | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED | 2024-06-06 |
EP3833335 | Pharmaceutical Composition Comprising Hmg-Coa Reductase Inhibitors And Fenofibrate | INTAS PHARMACEUTICALS LTD. | 2024-06-05 |
EP3694462 | Sanitary Napkin For Heavy Uterine Bleeding | GRUPO P.I. MABE S.A. DE C.V. | 2024-05-30 |
EP3630164 | Dulaglutide For The Treatment Of Chronic Kidney Disease | ELI LILLY AND COMPANY | 2024-05-23 |
EP3340989 | Mdm2 Inhibitors And Combinations Thereof | NOVARTIS AG | 2024-05-15 |
Top clients of Elkington And Fife Llp filing patent oppositions